TME Pharma (ALTME.PA) Stock Price
€0.107 2.7%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
1 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on TME Pharma, AI stock picks, stock alerts and much more.
ALTME.PA AI Stock Analysis
AI stock analysis for ALTME.PA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like TME Pharma (ALTME.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
TME Pharma (ALTME.PA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of TME Pharma (ALTME.PA), currently trading at €0.107, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ALTME.PA
-
TME Pharma N.
-
Symbol
ALTME.PA
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
10M
Similar Stocks
 |
Valneva SE VLA.PA |
€5.07 6.1% |
5 |
 |
Financière de Tubize SA TUB.BR |
€160 1.7% |
8 |
 |
OSE Immunotherapeutics SA OSE.PA |
€6.91 4.1% |
7 |
 |
UCB SA UCB.BR |
€195.5 1.5% |
6 |
 |
Innate Pharma S.A. IPH.PA |
€1.99 1.4% |
6 |
ALTME.PA Alternative Data
Web Traffic
TME Pharma receives an estimated 3260 monthly visitors to tmepharma.com.
-
Web Traffic
3260
-
Change from Previous Month
219.3%
-
3 Month Change
177.2%
-
YoY Change
177.2%
Youtube Subscribers
TME Pharma has 30 subscribers on its main Youtube channel.
-
Youtube Subscribers
30
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
3.2%
Job Postings
TME Pharma currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Twitter Followers
TME Pharma has 829 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.
-
Twitter Followers
829
-
Daily Change
0.1%
-
1 Month Change
0.1%
-
3 Month Change
1%
-
YoY Change
1%
LinkedIn Employees
According to LinkedIn, TME Pharma has 14 employees, down by -12.5% over the last month.
-
LinkedIn Employees
14
-
Daily Change
12.5%
-
1 Month Change
12.5%
-
3 Month Change
33.3%
-
YoY Change
33.3%
News Mentions
TME Pharma was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
TME Pharma has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
ALTME.PA Financials
ALTME.PA Key Metrics
-
Total Revenue
€0
-
Net Income
-€3.2M
-
Earnings per Share
-€0.12
-
Free cash flow
-€2.7M
-
EBITDA
-€2.7M
-
EBITDA Ratio
0
-
Total Assets
€2.9M
ALTME.PA 2-year Revenue & Income
ALTME.PA 2-year Free Cash Flow
ALTME.PA Technicals
ALTME.PA SMA
ALTME.PA RSI
FAQ
What's the current price of TME Pharma (ALTME.PA) Stock?
The price of an TME Pharma (ALTME.PA) share is €0.107.
What's the market cap of TME Pharma?
The current market cap of TME Pharma is 10M.
Should I buy or sell ALTME.PA?
TME Pharma shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, TME Pharma is better viewed as a hold or accumulate position while waiting for further developments.
Is TME Pharma a good investment?
The current analysis of TME Pharma's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in TME Pharma's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy TME Pharma (ALTME.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for TME Pharma stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to TME Pharma (ALTME.PA) that investors often compare it to?
TME Pharma (ALTME.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..
What is the forecast for TME Pharma's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast TME Pharma's stock price to be around €0.106 in 2026. Starting from the current price of €0.107, this represents a 0.9% change in price, indicating a neutral outlook for the stock.
How to buy TME Pharma (ALTME.PA) Stock?
TME Pharma stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy TME Pharma shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.